Brain-C Lab: Brain compensation dynamics in neurodegenerative diseases
We decipher molecular systems to
re-instate brain resilience against neurodegenerative diseases at the right
time in the right cells
Follow us at https://twitter.com/Neri_lab
We are pleased to consider applications from prospective PhD students and postdocs
NEWS NOVEMBER 2023:
1 postdoctoral position & 1
study-engineer position Systems Biology, Neuronal Vulnerability, and Neurodegenerative Diseases areavailable in the lab on the topic of ALS
systems and comparison to HD systems. Are you interested? do not wait to
apply. Informal inquiries are welcome.
1st conference on Extracellular Vesicles in Nervous Systems, a
first-of-its-kind event organized by ISEV, Rome, Italy, December 2023
+210 participants, + 100 posters, the conference is almost full but it is still possible to register. Interested? do not wait to join us! https://www.isev.org/evs-in-nervous-system
We use machine learning,
cell biology, and preclinical models to investigate and mitigate
neuronal decline in neurodegenerative diseases. We are seaking for 1-2
early- to mid-career French researchers (DR, CR, Pr, MCU, IR) with
established expertise in either extracellular vesicles or genome integrity to join and develop our
research on these topics. Interested by these opportunities? Feel
free to be in touch to learn more about our research in neurosciences.
2019: EMBO workshop on Network inference and Machine learning: are you interested to know about the ideas, data, and perspectives in the field shared during this workshop? Here's the public summary!
EMBO NIBD2019 public summary We plan for a second edition, stay tuned.
2019: NEUROFRANCE symposium on exocytosis and extracellular vesicles in brain development, maintenance, and disease. Symposium supported by the Société des Neurosciences and co-supported by the Société de Biologie Cellulaire Française (SBCF) and Société Française de Microscopie. See https://www.professionalabstracts.com/nf2019/iplanner/#/grid
Our primary goal is to understand how the capacity of the brain cell systems to maintain function and resist neurodegenerative disease is regulated on molecular, cellular and inter-cellular levels, how this may fail to slow down the progression of neurodegenerative disease processes, and how these mechanisms may be re-instated for therapeutic purposes. We study these questions in Huntington's disease (HD), a genetic neurodegenerative disease for which well-characterized models and highly dimensional datasets are available across species, and in Alzheimer's disease (AD).
Our knowledge discovery model is based on the combined use of systems modeling, cell biology and clinical research.
To understand how neurodegenerative diseases and aging may work on a systems level, we developed BioGemix —a data integration framework based on innovative machine learning approaches for biological precision in the analysis of dimensional data— and we use it for basic research and clinical discovery purposes.
Experimental biology involves cellular models such as human iPSC-derived cells, and C. elegans genetics.
We access human disease cohort data through our network of collaborators.
We work with the European HD Network (EHDN), APHP, the Gerontopole Ile-de-France, Paris Region initiatives, Sorbonne Université, CNRS, INSERM and patient associations.
We promote a strategic model based on a multi-disciplinary and trans-sectorial approach to address the following questions:
- What are the most important compensatory mechanisms that are lost in the course of neurodegenerative disease processes? How to re-instate these mechanisms to prolonge compensation and delay the progression of neurodegenerative diseases such as HD and AD?
- What are the factors allowing to predict the individual capacity for biological resilience in neurodegenerative disease and age-related stress? Along these lines, what are the molecular diagnosis and precision medicine markers allowing to predict the most likely course of neurodegenerative disease progression rate?